Pilot Study Evaluating Catheter Directed Thrombolysis Device in Acute Intermediate Risk Pulmonary Embolism

This is a pilot study of the Flow Medical Catheter, a catheter-based device used to deliver clot-dissolving medication directly to a blood clot in the lungs (pulmonary embolism). The study evaluates whether the device can be used safely and as intended in adults with intermediate-risk acute pulmonary embolism. All participants receive treatment with the study device; there is no comparison group.

NCT Number	NCT07681154
Lead Sponsor	Flow Medical Solutions, Inc.
Conditions	Pulmonary Embolism (PE), Pulmonary Embolism With Right Ventricle Enlargement
Enrollment	20 participants
Start Date	2026-10
Primary Completion	2027-05 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-02